Trhová kapitalizácia spoločnosti Midatech Pharma Plc
Aká je hodnota metriky Trhová kapitalizácia spoločnosti Midatech Pharma Plc?
Hodnota metriky Trhová kapitalizácia spoločnosti Midatech Pharma Plc je $1.63M
Aká je definícia metriky Trhová kapitalizácia?
Trhová kapitalizácia (Market cap) je trhová hodnota vydaných akcií obchodovanej spoločnosti a je rovná cene akcie v danom čase vynásobenej počtom kusov vydaných akcií.
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Trhová kapitalizácia spoločností v sektore Health Care sektor na LSE v porovnaní so spoločnosťou Midatech Pharma Plc
Čomu sa venuje spoločnosť Midatech Pharma Plc?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Firmy s metrikou trhová kapitalizácia podobnou spoločnosti Midatech Pharma Plc
- Hodnota metriky Trhová kapitalizácia spoločnosti Kisses from Italy je $1.63M
- Hodnota metriky Trhová kapitalizácia spoločnosti ADM plc je $1.63M
- Hodnota metriky Trhová kapitalizácia spoločnosti Killi je $1.63M
- Hodnota metriky Trhová kapitalizácia spoločnosti ArcPacific Resources je $1.63M
- Hodnota metriky Trhová kapitalizácia spoločnosti Westcore je $1.63M
- Hodnota metriky Trhová kapitalizácia spoločnosti SNP Schneider-Neureither & Partner SE je $1.63M
- Hodnota metriky Trhová kapitalizácia spoločnosti Midatech Pharma Plc je $1.63M
- Hodnota metriky Trhová kapitalizácia spoločnosti Therapix Biosciences je $1.63M
- Hodnota metriky Trhová kapitalizácia spoločnosti Enea AB (publ) je $1.64M
- Hodnota metriky Trhová kapitalizácia spoločnosti VIP Gloves je $1.64M
- Hodnota metriky Trhová kapitalizácia spoločnosti Aphelion Capital je $1.64M
- Hodnota metriky Trhová kapitalizácia spoločnosti CE Brands je $1.64M
- Hodnota metriky Trhová kapitalizácia spoločnosti Sky Gold je $1.64M